HFA Premium Access

Does prior MRA use limit eligibility for sacubitril valsartan in a heart failure clinic? Insights from real world experience and implications for ESC and NICE guidelines

Congress Presentation

About the speaker

Doctor Libor Myslivecek

Bristol Heart Institute, Bristol (United Kingdom of Great Britain & Northern Ireland)
0 follower

61 more presentations in this session

Real-world patterns of loop diuretics dose adjustment and association with outcomes in outpatients with chronic heart failure: observations from the ESC Heart Failure Long-Term Registry

Speaker: Doctor C. Kapelios (Athens, GR)

Thumbnail

Acute kidney failure and hyperkalaemia in patients with chronic hearth failure treated with aldosterone antagonists- a risk-benefit network meta-analysis

Thumbnail

Intermittent administration of levosimendan ambulatory in patients with advanced chronic heart failure: experience in our center.

Thumbnail

Sildenafil for chronic heart failure : a meta-analysis

Speaker: Mrs C. Ariano (Naples, IT)

Thumbnail

The dilemma of recurrent hyperkalaemia and use of renin-angiotensin-aldosterone system inhibitors in heart failure with reduced ejection fraction: a European multi-national targeted chart review

Speaker: Professor P. Rossignol (Monaco, MC)

Thumbnail

Access the full session

Poster Session 2 - Chronic Heart Failure – Treatment

Speakers: Doctor L. Myslivecek, Doctor C. Kapelios, Mrs C. Ariano, Professor P. Rossignol
Thumbnail

About the event

Image

Heart Failure 2018

26 May - 29 May 2018

Sessions Presentations